As a result, pharmaceutical companies are facing challenges when attempting to align supply levels with rapidly rising global demand for obesity therapies
So when EVOKE and EVOKE+ showed no benefit of semaglutide, it was disappointing but not surprising
Having the vitamin D injection and the IM injection is helping me a lot with the inflammation pain
It will end as a systems story about integration, coverage, and outcomes
However, tirzepatide's glucose-dependent mechanism of action means that hypoglycemia risk is low when used as monotherapy or with metformin
In a case series of 49 patients, the mean age was 51.2 years and the most common sites involved were the trunk, the head and neck, the extremities, and the acral areas [23]